Novocure PANOVA-4 Trial Shows Positive Cancer Results
Baar, Switzerland – March 2026 Novocure announced positive topline results from its Phase 2 PANOVA-4 clinical trial evaluating Tumor...
oncology research
Advertisement
Celcuity Reports Phase 3 Gedatolisib Results in Breast Cancer
Minneapolis, USA – March 9, 2026 Celcuity Inc. has announced the publication of positive Phase 3 VIKTORIA-1 clinical trial...
Telix ProstACT Phase 3 Study Shows Positive Safety Results
Melbourne, Australia & Indianapolis, United States – March 10, 2026 Telix Pharmaceuticals has announced that Part 1 of the...
Worldwide Completes Catalyst CRO Acquisition Deal
RESEARCH TRIANGLE PARK, N.C., and NOTTINGHAM, U.K., Feb. 16, 2026 — Global contract research organization Worldwide Clinical Trials has...
Mayo Clinic Advances Translational Oncology Clinical Trials
ROCHESTER, MINNESOTA & PHOENIX, ARIZONA | January 22, 2026 — The Advanced Clinical Trials and Translational Sciences Research Program...
Advertisements
CG Oncology Advances Phase 3 Timeline for NMIBC Trial
IRVINE, California | January 9, 2026 — CG Oncology, Inc., a late-stage clinical biopharmaceutical company, has announced an accelerated...
Telo Genomics Advances Blood-Based MRD Validation in Myeloma
Toronto, Ontario, December 18, 2025 — Telo Genomics Corp. has initiated a new retrospective blood-based minimal residual disease (MRD)...
Editas Medicine Advances Gene-Editing Therapy EDIT-401
Cambridge, Massachusetts – September 2, 2025 Editas Medicine, Inc. (Nasdaq: EDIT), a pioneering gene-editing biotechnology company, has nominated EDIT-401,...
Sumitomo Pharma Unveils Promising Data in Blood Cancers
Marlborough, Massachusetts – November 3, 2025 Sumitomo Pharma America, Inc. (SMPA) announced compelling new investigational data from multiple clinical...
GemPharmatech Forms Oncology Collaboration to Boost Antibody Innovation
Nanjing, China – October 22, 2025 GemPharmatech Co., Ltd., a global leader in genetically engineered mouse models and preclinical...
Advertisement
